- Display 15 Products per page
Published: February 5, 2014 | Price: $1,995.00 – $3,990.00
Medical Imaging Markets (X-Ray, CT, MRI, Ultrasound, PET, SPECT, Others) Medical imaging’s contributions to medical practice has made it an ever-growing industry with new technologies constantly being launched. Early and more accurate diagnoses are made possible via imaging scans, which in turn may lead to optimized treatment regimens. The Medical Imaging Markets report reviews current and potential world opportunities for medical imaging systems, which include x-ray, mammography, fluoroscopy, CT, MRI, Ultrasound, PET and SPECT, and fusion systems. This study forecasts...Published: February 5, 2014 | Price: $1,995.00 – $3,995.00
IVD manufacturers on the lookout for growth have targeted the Philippines among other places. Expanding economies worldwide need to increase healthcare spending to satisfy growing middle and low-to-middle class populations. IVD performs where healthcare spending increases as it is often the entry point of healthcare. This report, IVD Distribution in The Philippines, reviews the distribution of in vitro diagnostic products in this growing Asian Market. IVD in the Philippines includes: What Products Lines Are Distributed by Which Philippine IVD Companies...Published: January 1, 2014 | Price: $1,995.00 – $3,995.00
IVD in Singapore and Malaysia Regional opportunities are the focus of IVD manufacturers that seek marginal growth. Southeast Asia represents a unique market for healthcare providers and their various business suppliers, including the in vitro diagnostics (IVD) industry. Kalorama details in this report two countries expected to provide business for IVD manufacturers: Singapore and Malaysia. IVD in Singapore and Malaysia contains the following information: Healthcare Statistics for Singapore and Malaysia Significant Hospitals in both countries The Clinical Lab Market in...Published: November 22, 2013 | Price: $1,995.00 – $4,000.00
The World Market for Hematology Used for both critical and routine testing, hematology is a central part of IVD. CBCs contribute to the general assessment of health for patients during regular check-ups. Conditions such as anemia, other blood disorders, infection, allergy, iron and vitamin deficiencies are easily diagnosed through a CBC. This report, authored by Kalorama Analyst Emil Salazar, defines the market worldwide for analyzers, point of care tests, stains and slides and imaging systems used in hematology testing. Hematology...Published: October 25, 2013 | Price: $1,995.00 – $3,900.00
What is the procedure, for establishing reimbursement for an IVD test product? What companies have been successful and how? What changes will IVD makers face in the near-term. This Kalorama Information report, Reimbursement for In Vitro Diagnostic Tests, answers these questions and provides authoritative data for IVD business planners. One of the critical factors for the success of an IVD product is reimbursement. Reimbursement is a critical component of the health care landscape and will continue to have a major...Published: August 5, 2013 | Price: $1,995.00 – $3,990.00
Australia represents a highly competitive IVD market with established international players, a highly developed export-intensive domestic industry, and highly consolidated clinical lab and testing industry. While other developed IVD markets in North America, Europe and Japan are not estimated to be achieving above 3% annual growth, the Australian IVD market has grown at an average of roughly 5% through the past five years. This rate of growth is projected to more or less continue with a stable funding environment through...Published: January 31, 2013 | Price: $1,995.00 – $3,990.00
IVD Procedure Volume and Pricing Analysis This report examines the global procedure volumes for IVD and laboratory tests. It covers only commercialized tests, specifically excluding those that are developmental or used primarily for research purposes.. Point of Care (Glucose, Pregnancy, Other) CoreLab (General Chemistries, Blood Gas Analyzers, Urinalysis, Immunoassays Infectious Disease, Cardiac Markers, Diabetes/HbA1c, Autoimmune) Molecular (Infectious Disease [inc. molecular tests for HIV, Hepatitis, STDs, HAI, Respiratory, Other], Oncology, Inherited Disease, Other) Hematology Coagulation (PT, PTT) Microbiology (Automated Panels, Manual...Published: December 6, 2012 | Price: $1,995.00 – $8,400.00
The World Market for Point of Care (POC) Diagnostics Visit our 'Point of Care Testing' curated page for complete industry coverage. Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the...Published: June 15, 2012 | Price: $1,995.00 – $3,990.00
Veterinary diagnostics have incorporated technologies and methods gained from human diagnostics and mainstream healthcare to develop a now full-fledged sister market that remains open to further innovation. Major diagnostic methods in mainstream healthcare – immunodiagnostics, molecular testing (including nucleic acid testing), hematology and clinical chemistry – now have standard applications in the veterinary care of companion (pets) and food animals (livestock and production animals). This report, The World Market for Veterinary Diagnostics, looks at these trends and details: Markets for Consumer Animal...Published: January 1, 2012 | Price: $1,995.00 – $4,995.00
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents the fourth time that Kalorama Information has taken a comprehensive look at oncology therapeutics. The report focuses on several segments for cancer treatment including: Chemotherapy, - Subcategories include Alkylating Agents, Antimetabolites, Cytotoxic Agents, Plant Derivatives - Brands such as Elotaxin, Taxotere, Gemzar, Alimta and Temodar, with Market Share for each Hormone Therapy: - Subcategories include Corticosteroids, Hormone...Published: November 1, 2010 | Price: $1,995.00 – $3,990.00
Physician Office Laboratory (POL) Testing Markets Worldwide: Status Quo and Future Trends The physician office laboratory (POL) is usually not broken out in market research reports covering the medical device and diagnostic industry. Numbers are often simply grouped in with hospital and service lab sales. But for marketing strategy, knowing where diagnostic tests occur is as important as the revenue numbers. Now, Kalorama Information shines further light onto the POL testing market with its report, Physician office Laboratory (POL) Testing...Published: November 1, 2007 | Price: $1,995.00 – $3,990.00
No longer is cell-based diagnostics simply a histological study of biopsied and surgical tissues. Combinations of tests and technologies are coming together to create a new map of cell diagnostics. Image cytometry, microfluidics, microarrays, and biosensors, special immunohistochemical and in situ hybridization probes are creating new approaches to cell and tissue observation, diagnostics and pharmacogenomics. This report covers assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood,...Published: February 1, 2007 | Price: $1,995.00 – $3,990.00
Lateral flow tests, also known as immunochromatographic strip (ICS) tests, offer dramatic benefits in the diagnostic process that point towards a robust market. LF tests are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and manufacturing. Rapid point of care testing devices will play an increasingly important role in the decentralization of medicine, where testing is moving away...Published: February 1, 2007 | Price: $1,995.00 – $5,990.00
Contrast agents and radiopharmaceuticals have revolutionized in vivo imaging. Technical developments in contrast media and imaging techniques is combining with the trends toward both the functional and molecular understanding of disease to create a rapidly growing marketplace in these agents. The introduction and now brisk ongoing development of contrast media for traditional radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron-emission tomography (PET), and single-photon emission computed tomography (SPECT), are now allowing for the expansion of diagnostic capabilities of...Published: September 1, 2006 | Price: $1,995.00 – $7,800.00
This comprehensive evaluation of the blood industry provides an analysis of all the key market segments involved in this industry, including blood products such as: Red Blood Cells (RBCs) Immunoglobulins Albumin Other Plasma Products Synthetic HBOC and PFC Agents Recombinant Factors And blood supply management products, including: Blood Collection Equipment Automated Blood Collection Equipment Blood Banking and Plasmapheresis Testing Blood Typing Human Immunodeficiency Virus (HIV) Testing Hepatitis A Virus Testing Hepatitis B Virus Testing Hepatitis C Virus Testing Human T-Cell...